When using inhaled corticosteroids for the treatment of asthma, COPD, and other airways disease, authors of a new study warn to proceed with caution.
Daily Dose: Pediatric Asthma Risk Score
Your daily dose of clinical news you may have missed.
NAVIGATOR: Tezepelumab Reduces Asthma Exacerbations by More than Half
In our latest podcast episode, Njira Lugogo, MD, discusses NAVIGATOR data she presented at ATS 2022 that showed clinical responses to treatment with tezepelumab.
AAAAI 2023: Pediatric Asthma Risk Score Validated in Multi-cohort Study
Future studies may consider PARS the new gold standard in predicting pediatric asthma risk, said study authors.
Eternal Springs
Doctors, especially primary care doctors, love stories. We love hearing them from patients and telling them to one another. “Anecdotal learning” it’s called by some (somewhat derisively because it’s not science).
Tezepelumab FDA-approved for Self-administration by Patients with Severe Asthma
The approval offers patients the choice to administer the monoclonal antibody at home using a prefilled device or to continue to receive it in a clinical setting.
Air Pollution Independently Linked to Asthma Exacerbation in Urban-dwelling Children
Asthma exacerbations in children living in low-income urban areas were significantly associated with reduced air quality and specific pollutants in a new analysis.